List of works - Fabiola Atzeni

A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data

scientific article

Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia.

scientific article published in September 2005

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

scientific article

Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes

scientific article published on 21 November 2008

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.

scientific article published on 7 May 2008

Antigen preparation for immunological studies in systemic autoimmune diseases

scientific article published on August 2007

Autoimmunity and anti-TNF-alpha agents

scientific article

B lymphocyte intestinal homing in inflammatory bowel disease

scientific article

Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis

scientific article

Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts

scientific article published on 19 May 2015

CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease

scientific article published on 09 September 2012

Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others).

scientific article

Central motor control failure in fibromyalgia: a surface electromyography study

scientific article

Chronic widespread pain in the spectrum of rheumatological diseases

scientific article

Clinical and laboratory aspects of Ro/SSA-52 autoantibodies ⬇️

scientific article published on September 18, 2010

Clinimetric evaluations of patients with chronic widespread pain

scientific article published on April 2011

Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"

scientific article published on 07 August 2018

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

scientific article published on 8 May 2017

Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients

scientific article published on 13 August 2020

Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect

scientific article published on 18 August 2009

Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis

scientific article published on 22 June 2020

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability.

scientific article published on 14 July 2016

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study

scientific article published on 11 February 2020

Early treatment in early undifferentiated arthritis.

scientific article published on 20 October 2011

Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.

scientific article

Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study

scientific article published on 01 April 2010

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

scientific article

Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis

scientific article published on May 17, 2013

Environment and systemic lupus erythematosus: an overview

scientific article

Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study

scientific article published on 31 August 2010

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

scientific article published on 15 March 2013

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

scientific article

Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity

scientific article published on 8 February 2014

Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years.

scientific article published on 19 June 2015

Hand osteoarthritis.

scientific article

How to measure chronic pain: New concepts

scientific article published on February 2015

Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy

scientific article published on 13 May 2016

Incidence of cancer in patients with spondyloarthritis treated with anti-tnf drugs

scientific article published on 8 September 2017

Increased neural sympathetic activation in fibromyalgia syndrome

scientific article published on June 2006

Is atherosclerosis an autoimmune disease?

scientific article

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

scientific article

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity

scientific article published on 01 March 2020

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

scientific article published on 13 July 2012

Long-term safety of abatacept in patients with rheumatoid arthritis.

scientific article published on 22 June 2013

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

scientific article

Measurement of Serum Klotho in Systemic Sclerosis.

scientific article

Multidisciplinary approach to fibromyalgia: what is the teaching?

scientific article published on April 2011

New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis).

scientific article published on May 2004

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

scientific article published in January 2013

Osteoarthritis of the spine

scientific article

Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder

scientific article published on November 1, 2012

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease

scientific article published on July 1, 2011

Pain in systemic inflammatory rheumatic diseases.

scientific article published on February 2015

Physical and rehabilitative approaches in osteoarthritis

scientific article

Position paper of Italian rheumatologists on the use of biosimilar drugs.

scientific article

Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review

scientific article

Potential target of infliximab in autoimmune and inflammatory diseases

scientific article published on 16 April 2007

Predicting response to anti-TNF treatment in rheumatoid arthritis patients

scientific article published on 27 January 2009

Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores

scientific article published on 2 June 2013

Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort

scientific article published on 01 July 2019

Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report

scientific article

Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients.

scientific article

Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases

scientific article

Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry

scientific article published on 31 December 2009

Switching rheumatoid arthritis treatments: an update.

scientific article published on 22 January 2011

TLR-4 and VEGF polymorphisms in chronic periaortitis

scientific article

TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice

scientific article published on 01 September 2009

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma

scientific article

The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases

scientific article

The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis

scientific article

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts

article

The role of echocardiographic techniques in connective tissue diseases

scientific article

Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study

scientific article

Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal

scientific article

Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry

scientific article published on 30 July 2009

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.

scientific article published on 30 October 2017

What is the role of rituximab in the treatment of rheumatoid arthritis?

scientific article published on 07 March 2007

List of works by Fabiola Atzeni

A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data

Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia.

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.

Antigen preparation for immunological studies in systemic autoimmune diseases

Autoimmunity and anti-TNF-alpha agents

B lymphocyte intestinal homing in inflammatory bowel disease

Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis

Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts

CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease

Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others).

Central motor control failure in fibromyalgia: a surface electromyography study

Chronic widespread pain in the spectrum of rheumatological diseases

Clinical and laboratory aspects of Ro/SSA-52 autoantibodies ⬇️

Clinimetric evaluations of patients with chronic widespread pain

Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries

Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients

Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect

Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability.

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study

Early treatment in early undifferentiated arthritis.

Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.

Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis

Environment and systemic lupus erythematosus: an overview

Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity

Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years.

Hand osteoarthritis.

How to measure chronic pain: New concepts

Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy

Incidence of cancer in patients with spondyloarthritis treated with anti-tnf drugs

Increased neural sympathetic activation in fibromyalgia syndrome

Is atherosclerosis an autoimmune disease?

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Long-term safety of abatacept in patients with rheumatoid arthritis.

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

Measurement of Serum Klotho in Systemic Sclerosis.

Multidisciplinary approach to fibromyalgia: what is the teaching?

New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis).

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

Osteoarthritis of the spine

Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease

Pain in systemic inflammatory rheumatic diseases.

Physical and rehabilitative approaches in osteoarthritis

Position paper of Italian rheumatologists on the use of biosimilar drugs.

Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review

Potential target of infliximab in autoimmune and inflammatory diseases

Predicting response to anti-TNF treatment in rheumatoid arthritis patients

Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores

Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort

Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report

Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients.

Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases

Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry

Switching rheumatoid arthritis treatments: an update.

TLR-4 and VEGF polymorphisms in chronic periaortitis

TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma

The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases

The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts

The role of echocardiographic techniques in connective tissue diseases

Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study

Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal

Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.

What is the role of rituximab in the treatment of rheumatoid arthritis?